Loqtorzi

toripalimab-tpzi

Approval

ApplicationBLA 761240
Approval dateOct 27, 2023
Approval year2023
SponsorCoherus Biosciences INC

FDA-approved use

To treat recurrent or metastatic nasopharyngeal carcinoma when used together with or following other therapies

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Loqtorzi: